Safety and efficacy of stem cell therapy in acute myocardial infarction: a systematic review and meta-analysis of adverse events, infarct size and LV ejection fraction assessed by CMRI
Introduction The current standard treatment for ST-segment elevation myocardial infarction is prompt reperfusion through primary percutaneous coronary intervention. However, myocardial infarction remains the leading cause of heart failure, contributing to prolonged hospital stay and a 30% rehospital...
Saved in:
| Main Authors: | Dede Moeswir, Putri Nurbaeti, Hari Hendarto, Muhammad Farhan Abdul Rahman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | Open Heart |
| Online Access: | https://openheart.bmj.com/content/12/1/e003301.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RESULTS OF OFF-PUMP MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH LV EJECTION FRACTION <45 %
by: I. M. Sharipov, et al.
Published: (2019-06-01) -
The correlation between lipoprotein(a) and major adverse cardiovascular events in patients with acute myocardial infarction combined with heart failure with preserved ejection fraction
by: Xiaodong Zhang, et al.
Published: (2025-06-01) -
The Effect Of Demographic Factors And Comorbidities On Ejection Fraction Outcome In Acute Myocardial Infarction Patients
by: Kausar Malik, et al.
Published: (2024-09-01) -
Gender features of heart failure with preserved ejection fraction in patients with myocardial infarction on the background of hypertension
by: V. D. Syvolap, et al.
Published: (2017-06-01) -
Echocardiographic correlates of cardiac fibrosis in patients with myocardial infarction and preserved left ventricular ejection fraction
by: N. V. Fedorova, et al.
Published: (2019-06-01)